|Prevention of bleeding in patients with atrial fibrillation undergoing PCI|
CM Gibson, R Mehran, C Bode, J Halperin, FW Verheugt, P Wildgoose, ...
New England Journal of Medicine 375 (25), 2423-2434, 2016
|Safety and tolerability of CSL112, a reconstituted, infusible, plasma-derived apolipoprotein AI, after acute myocardial infarction: the AEGIS-I trial (ApoA-I event reducing in†…|
C Michael Gibson, S Korjian, P Tricoci, Y Daaboul, M Yee, P Jain, ...
Circulation 134 (24), 1918-1930, 2016
|EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary†…|
CM Gibson, RP Giugliano, RA Kloner, C Bode, M Tendera, A JŠnosi, ...
European heart journal 37 (16), 1296-1303, 2016
|d-Dimer elevation and adverse outcomes|
R Halaby, CJ Popma, A Cohen, G Chi, MR Zacarkim, G Romero, ...
Journal of thrombosis and thrombolysis 39, 55-59, 2015
|Recurrent hospitalization among patients with atrial fibrillation undergoing intracoronary stenting treated with 2 treatment strategies of rivaroxaban or a dose-adjusted oral†…|
CM Gibson, DS Pinto, G Chi, D Arbetter, M Yee, R Mehran, C Bode, ...
Circulation 135 (4), 323-333, 2017
|The IMPROVEDD VTE risk score: incorporation of D-dimer into the IMPROVE score to improve venous thromboembolism risk stratification|
CM Gibson, AC Spyropoulos, AT Cohen, RD Hull, SZ Goldhaber, ...
TH open 1 (01), e56-e65, 2017
|Extended-duration betrixaban reduces the risk of stroke versus standard-dose enoxaparin among hospitalized medically ill patients: an APEX trial substudy (acute medically ill†…|
CM Gibson, G Chi, R Halaby, S Korjian, Y Daaboul, P Jain, D Arbetter, ...
Circulation 135 (7), 648-655, 2017
|Vitamin K2 supplementation and arterial stiffness among renal transplant recipients—a single-arm, single-center clinical trial|
AG Mansour, E Hariri, Y Daaboul, S Korjian, A El Alam, AD Protogerou, ...
Journal of the American Society of Hypertension 11 (9), 589-597, 2017
|The safety and efficacy of full-versus reduced-dose betrixaban in the Acute Medically Ill VTE (Venous Thromboembolism) Prevention With Extended-Duration Betrixaban (APEX) trial|
CM Gibson, R Halaby, S Korjian, Y Daaboul, DF Arbetter, MK Yee, ...
American Heart Journal 185, 93-100, 2017
|Asymptomatic deep vein thrombosis is associated with an increased risk of death: insights from the APEX trial|
A Kalayci, CM Gibson, G Chi, MK Yee, S Korjian, S Datta, T Nafee, ...
Thrombosis and Haemostasis 118 (12), 2046-2052, 2018
|Comparison of fatal or irreversible events with extended‐duration betrixaban versus standard dose enoxaparin in acutely ill medical patients: an APEX trial substudy|
CM Gibson, S Korjian, G Chi, Y Daaboul, P Jain, D Arbetter, ...
Journal of the American Heart Association 6 (7), e006015, 2017
|Sickle cell nephropathy: an update on pathophysiology, diagnosis, and treatment|
E Hariri, A Mansour, A El Alam, Y Daaboul, S Korjian, S Aoun Bahous
International Urology and Nephrology 50, 1075-1083, 2018
|The impact of the COVID-19 pandemic on cardiovascular fellows-in-training: a national survey|
P Rao, J Diamond, S Korjian, L Martin, M Varghese, JD Serfas, R Lee, ...
Journal of the American College of Cardiology 76 (7), 871-875, 2020
|Rationale and design of Apo-I Event Reduction in Ischemic Syndromes I (AEGIS-I): a phase 2b, randomized, placebo-controlled, dose-ranging trial to investigate the safety and†…|
CM Gibson, S Korjian, P Tricoci, Y Daaboul, JH Alexander, PG Steg, ...
American Heart Journal 180, 22-28, 2016
|The CSL112-2001 trial: Safety and tolerability of multiple doses of CSL112 (apolipoprotein AI [human]), an intravenous formulation of plasma-derived apolipoprotein AI, among†…|
CM Gibson, M Kerneis, MK Yee, Y Daaboul, S Korjian, AP Mehr, P Tricoci, ...
American heart journal 208, 81-90, 2019
|Safety and efficacy of double vs. triple antithrombotic therapy in patients with atrial fibrillation with or without acute coronary syndrome undergoing percutaneous coronary†…|
G Gargiulo, CP Cannon, CM Gibson, A Goette, RD Lopes, J Oldgren, ...
European Heart Journal-Cardiovascular Pharmacotherapy 7 (FI1), f50-f60, 2021
|Haloperidol versus ondansetron for treatment of established nausea and vomiting following general anesthesia: a randomized clinical trial|
VG Yazbeck-Karam, SM Siddik-Sayyid, HB Barakat, S Korjian, MT Aouad
Anesthesia & Analgesia 124 (2), 438-444, 2017
|Medical education in a foreign language and history-taking in the native language in Lebanon–a nationwide survey|
V Abi Raad, K Raad, Y Daaboul, S Korjian, N Asmar, M Jammal, ...
BMC medical education 16, 1-6, 2016
|Usefulness of rivaroxaban for secondary prevention of acute coronary syndrome in patients with history of congestive heart failure (from the ATLAS-ACS-2 TIMI-51 trial)|
S Korjian, E Braunwald, Y Daaboul, M Mi, DL Bhatt, FWA Verheugt, ...
The American Journal of Cardiology 122 (11), 1896-1901, 2018
|Symptomatic event reduction with extended-duration betrixaban in acute medically ill hospitalized patients|
CM Gibson, T Nafee, MK Yee, G Chi, S Korjian, Y Daaboul, F AlKhalfan, ...
American Heart Journal 198, 84-90, 2018